These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21951664)

  • 1. RUNX2 expression in developing human bones and various bone tumors.
    Sugawara M; Kato N; Tsuchiya T; Motoyama T
    Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells.
    Makita N; Suzuki M; Asami S; Takahata R; Kohzaki D; Kobayashi S; Hakamazuka T; Hozumi N
    Gene; 2008 Apr; 413(1-2):8-17. PubMed ID: 18321663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
    Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
    Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid induces either differentiation or apoptosis in MG-63 osteosarcoma lineage.
    Valenti MT; Zanatta M; Donatelli L; Viviano G; Cavallini C; Scupoli MT; Dalle Carbonare L
    Anticancer Res; 2014 Apr; 34(4):1617-27. PubMed ID: 24692690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of bone development and extracellular matrix protein genes by RUNX2.
    Komori T
    Cell Tissue Res; 2010 Jan; 339(1):189-95. PubMed ID: 19649655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of c-fos expression in benign and malignant musculoskeletal lesions.
    Weisstein JS; Majeska RJ; Klein MJ; Einhorn TA
    J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
    Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
    J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.
    Eliseev RA; Schwarz EM; Zuscik MJ; O'Keefe RJ; Drissi H; Rosier RN
    Exp Cell Res; 2006 Jan; 312(1):40-50. PubMed ID: 16259979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
    Hou CH; Hsiao YC; Fong YC; Tang CH
    Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line.
    Tang X; Lu X; Guo W; Ren T; Zhao H; Zhao F; Tang G
    Eur J Cancer Prev; 2010 Nov; 19(6):466-71. PubMed ID: 20683191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
    Nifuji A; Miura N; Kato N; Kellermann O; Noda M
    J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational regulation is a control point in RUNX2/Cbfa1 gene expression.
    Sudhakar S; Li Y; Katz MS; Elango N
    Biochem Biophys Res Commun; 2001 Nov; 289(2):616-22. PubMed ID: 11716520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
    Singhatanadgit W; Salih V; Olsen I
    Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activity of Runx2 mediated by hyaluronan during chondrocyte differentiation.
    Tanne Y; Tanimoto K; Tanaka N; Ueki M; Lin YY; Ohkuma S; Kamiya T; Tanaka E; Tanne K
    Arch Oral Biol; 2008 May; 53(5):478-87. PubMed ID: 18242579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
    PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis.
    Wang Y; Belflower RM; Dong YF; Schwarz EM; O'Keefe RJ; Drissi H
    J Bone Miner Res; 2005 Sep; 20(9):1624-36. PubMed ID: 16059634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental pathways hijacked by osteosarcoma.
    Mortus JR; Zhang Y; Hughes DP
    Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between bone morphogenetic protein and neoplastic bone diseases.
    Jin Y; Yang LJ
    Clin Orthop Relat Res; 1990 Oct; (259):233-8. PubMed ID: 2208862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
    Shui C; Spelsberg TC; Riggs BL; Khosla S
    J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.